Around 70% of the patients have elevated levels of the lymphangiogenic factor VEGFD, which is a biomarker for the diagnosis of LAM (137), and is produced by the LAM cells (105). The gene discussed is VEGFD; the disease is lymphangioleiomyomatosis.